¿statnews.com está no funciona hoy?

¿Qué pasó con statnews.com? ¿Por qué el sitio web dejó de funcionar y no funcionó? Aquí puedes ver quién más tiene el mismo problema con statnews.com, así como las posibles soluciones. Según nuestras estadísticas, lo siguiente no suele funcionar: .

Estado actual: Sin fallas

Por el momento, de acuerdo con nuestros datos, statnews.com está funcionando bien, pero es posible que haya fallas únicas. Si statnews.com no funciona para usted, informe su problema y escriba un comentario.
Agregar comentario

¿Qué hacer si el sitio statnews.com no está disponible? Prueba nuestra guía.

statnews.com - informes de cortes en las últimas 24 horas

statnews.com - informes de errores y fallas, métodos de solución de problemas

Deja tu comentario describiendo la falla y comparte con otros usuarios cómo resolver el problema.
  • No es necesario registrarse.
  • No se permite publicar mensajes con lenguaje obsceno e insultos, así como infringir la ley.
  • Enlaces activos en el texto del mensaje no se publica, sino que se muestra en texto sin formato.
  • Está prohibido publicar datos personales propios y de otras personas: direcciones, números de teléfono, correos electrónicos, cuentas en mensajería instantánea, etc.

Información técnica

Título de la página principal:
STAT | Reporting from the frontiers of health and medicine
Descripción de la página principal:
Your go-to source for the latest news in health, science and medicine. Sign up for STAT+ for exclusive analysis of biotech, pharma, and the life sciences.
Protocolo:
https
Código de estado:
200
Tamaño de página:
312.9 KB
Tiempo de respuesta:
0.135seg.
IP:
104.18.29.205
Encabezados de respuesta:
date: Mon, 30 Sep 2024 23:36:18 GMT
content-type: text/html; charset=UTF-8
transfer-encoding: chunked
connection: close
link: <https://www.statnews.com/wp-json/>; rel="https://api.w.org/"
via: 1.1 varnish, 1.1 varnish
fastly-ssl: 1
x-ttl: default
age: 1648
x-served-by: cache-bos4674-BOS, cache-ams2100124-AMS
x-cache: HIT, HIT
x-cache-hits: 14, 1
x-timer: S1727739378.035984,VS0,VE1
vary: Accept-Encoding,Fastly-SSL,Fastly-SSL
cf-cache-status: DYNAMIC
server: cloudflare
cf-ray: 8cb808c89fc76618-AMS

Encabezados de SEO

h1 STAT — Reporting from the frontiers of health and medicine
h2 Latest
h3 STAT Plus: How much more are health care’s bosses making than their employees?
h3 STAT Plus: J&J backs down on plan to switch payments to some 340B hospitals
h3 STAT Plus: DCVC Bio founders look for more quick returns, less overhyped AI, with new $400 million fund
h3 The fraught history of the pelvic exam
h3 STAT Plus: Steward Health Care CEO Ralph de la Torre will resign
h3 Sickle cell community scrambles to find safe plan after a drug is pulled from the market
h2 Don't Miss
h2 Top Stories
h3 STAT Plus: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion
h3 STAT Plus: Prime Medicine shrinks CRISPR ambitions and gets cash infusion from Bristol Myers Squibb
h3 Marburg virus outbreak in Rwanda draws concern over possibility of international spread
h3 STAT Plus: Roche seeks to project confidence on its obesity drugs — and sees room to make its mark
h3 STAT Plus: Q&A: Why medical AI and value-based care may be made for each other
h2 Most Read
h3 HPV vaccine, cervical cancer study delivers historic results
h3 The pelvic exam’s uncomfortable history
h3 After caring for bird flu case in Missouri, 4 more health care workers fell ill
h3 Fauci recovering at home following hospitalization for West Nile virus infection
h3 Readout Newsletter: Prime Medicine, DCVC Bio, Arbor, Atkis
h2 Most Read In STAT+
h3 STAT Plus: Health care CEOs dialed back 2023 pay, still made $3.5 billion
h3 STAT Plus: Prime Medicine shrinks CRISPR ambitions and gets cash infusion from Bristol Myers Squibb
h3 STAT Plus: Novartis, Generate:Biomedicines enter AI drug development deal
h3 STAT Plus: J&J backs down in HRSA clash over 340B rebate plan
h3 STAT Plus: DCVC Bio, a Silicon Valley VC firm, launches a $400 million fund
h2 Sponsored
h2 Newsletters
h3 STAT Plus: How much more are health care’s bosses making than their employees?
h3 A radiopharmaceuticals startup raises $175 million
h3 STAT Plus: Why are Genentech cancer researchers worried?
h2 STAT+
h3 Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.
h2 Trending Now
h3 STAT Plus: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion
h3 STAT Plus: Prime Medicine shrinks CRISPR ambitions and gets cash infusion from Bristol Myers Squibb
h3 STAT Plus: Novartis strikes AI drug development deal with Generate:Biomedicines
h3 STAT Plus: J&J backs down on plan to switch payments to some 340B hospitals
h3 STAT Plus: DCVC Bio founders look for more quick returns, less overhyped AI, with new $400 million fund
h2 Events
h3 2024 STAT Summit
h2 Trackers
h3 Obesity Drug Tracker
h3 CRISPR Tracker
h3 Generative AI Tracker
h3 Breakthrough Device Tracker
h2 Reports
h3 STAT’s guide to interpreting clinical trial results
h2 Targeting cancer: the new frontier of immunotherapy and precision oncology
h2 Ranking biotech’s top venture capital firms
h2 Podcasts
h2 The Readout LOUD
h2 First Opinion Podcast
h2 Color Code
h2 More Stories
h3 STAT Plus: How much more are health care’s bosses making than their employees?
h3 STAT Plus: J&J backs down on plan to switch payments to some 340B hospitals
h3 STAT Plus: DCVC Bio founders look for more quick returns, less overhyped AI, with new $400 million fund
h3 The fraught history of the pelvic exam
h3 STAT Plus: Steward Health Care CEO Ralph de la Torre will resign
h3 Sickle cell community scrambles to find safe plan after a drug is pulled from the market
h3 Four more health care workers reported illnesses after caring for bird flu case in Missouri
h3 WHO director general: A breakthrough global agreement on combatting antimicrobial resistance
h3 STAT Plus: Regeneron, Sanofi blockbuster Dupixent wins FDA approval for COPD
h3 STAT Plus: Why are Genentech cancer researchers worried?
h3 Sequencing wastewater material may be the key to getting a grip on the H5N1 bird flu outbreak
h3 STAT Plus: Dispute over Duchenne gene therapy highlights thorny access issues
h3 STAT Plus: Q&A: MedStar Health’s Raj Ratwani on health AI and the battle raging over regulation
h3 STAT Plus: Roche seeks to project confidence on its obesity drugs — and sees room to make its mark
h3 Marburg virus outbreak in Rwanda draws concern over possibility of international spread
h3 Sickle cell community scrambles to find safe plan after a drug is pulled from the market
h3 Sequencing wastewater material may be the key to getting a grip on the H5N1 bird flu outbreak
h3 STAT Plus: Humana cutting Medicare Advantage plans that cover 10% of members
h3 Q&A: Former NIH director Francis Collins on a Trump administration, science, and God
h3 STAT Plus: Pharmalittle: We’re reading about CVS under investor pressure, a final warning to J&J and more
h3 STAT Plus: Up and down the ladder: The latest comings and goings
h3 STAT Plus: Pharmalittle: We’re reading about a new schizophrenia drug, a U.N. pledge on AMR and more
h3 STAT Plus: Cassava Sciences and former execs, facing SEC charges for misleading claims, agree to fines
h3 STAT Plus: FDA approves schizophrenia drug that could alter how disorder is treated
h3 STAT Plus: Medicare will continue its cautious approach to paying for Alzheimer’s drugs
h3 The fraught history of the pelvic exam
h3 WHO director general: A breakthrough global agreement on combatting antimicrobial resistance
h3 Sequencing wastewater material may be the key to getting a grip on the H5N1 bird flu outbreak
h3 STAT Plus: Why Biohaven will test the FDA’s regulatory limits
h3 STAT Plus: Gene therapy for sickle cell disease remains a tough business model — and may never work
h3 STAT Plus: Congress must reauthorize the Older Americans Act to keep seniors safe from heat
h2 Newsletters
h2 Our Picks
h3 STAT Plus: Can Anne Wojcicki save 23andMe?
h3 STAT Plus: The little-known Chinese biotech whose cancer drug beat Keytruda has global ambitions
h3 How I fought Big Pharma on insulin prices — and won
h3 Millions of Americans want to quit smoking. Critics say drugmakers and the FDA are failing them
h3 STAT Plus: 12 people shaping psychedelics drug development
h3 A failing health care system caused my husband’s death
h3 STAT Plus: Inside the quiet strategy pharma giants are using to fend off generics and drive up the cost of medicines
h3 STAT Plus: A new cell therapy company takes its vision from four founders, and its skin from George Church
h2 Biotech
h3 STAT Plus: AbbVie Parkinson’s drug helps improve symptoms in late-stage study
h3 STAT Plus: AbbVie Parkinson’s drug helps improve symptoms in late-stage study
h3 STAT Plus: ARCH Venture Partners raises $3 billion for a new biotech fund
h3 STAT Plus: Pfizer pulls sickle cell treatment Oxbryta off global markets
h2 Pharma
h3 STAT Plus: What the withdrawal of its sickle cell drug means for Pfizer, patients, and the FDA
h3 STAT Plus: What the withdrawal of its sickle cell drug means for Pfizer, patients, and the FDA
h3 STAT Plus: Pharmalittle: We’re reading about Pfizer pulling a sickle cell pill, Moderna getting scolded, and more
h3 STAT Plus: Moderna is scolded by a U.K. trade group for offering kids $2,000 to participate in a Covid trial
h2 Health
h3 Morning Rounds: How much did health care’s top-earning CEO make in 2023?
h3 Morning Rounds: How much did health care’s top-earning CEO make in 2023?
h3 The FDA is ‘making sandwiches,’ ‘breakfast salad’ in DC, and what keeps us from choking on food
h3 Higher buprenorphine doses prevent hospitalization of people with fentanyl addiction, study finds
h2 Politics
h3 STAT Plus: Hassan indicates she’s open to tweaks on site-neutral payment reforms
h3 STAT Plus: Hassan indicates she’s open to tweaks on site-neutral payment reforms
h3 STAT Plus: Biden administration axes proposal to mandate more drug price transparency in Medicaid
h3 STAT Plus: FDA introduces plan to assess safety of common chemicals added to food
h2 Video
h3 A history of mpox so far
h3 STAT Plus: The little-known bill that made drugs more affordable
h3 Why clinicians are reconsidering race-based algorithms
h3 STAT Plus: How drug patents pave the way to profit
h2 Health tech
h3 STAT Plus: Epic Systems has been challenged in court before, but it’s different this time
h3 STAT Plus: Epic Systems has been challenged in court before, but it’s different this time
h3 STAT Plus: Sleep apnea alert on Apple Watch: What does it mean, and how does it work?
h3 STAT Plus: Can AI reduce health care fraud, AI firm in Texas AG’s crosshairs, and more
h2 In the Lab
h3 STAT Plus: Q&A: How scientists aim to kill cancers by starving them
h3 STAT Plus: Q&A: How scientists aim to kill cancers by starving them
h3 STAT Plus: Research misconduct claims are growing. Will new rules help universities investigate?
h3 Long-overlooked scientist shares Lasker Award with other GLP-1 researchers
h2 Hospitals
h3 STAT Plus: Two reports, two dramatically different views of nonprofit hospitals’ tax breaks
h3 STAT Plus: Two reports, two dramatically different views of nonprofit hospitals’ tax breaks
h3 STAT Plus: Ascension, other hospitals played active roles to take medical billing company R1 RCM private
h3 STAT Plus: Dana-Farber CEO Laurie Glimcher to step down, saying ‘we must look to the next generation’
h2 Insurance
h3 STAT Plus: Insurers went all-in on Medicare Advantage. Now, some are scaling back
h3 STAT Plus: Insurers went all-in on Medicare Advantage. Now, some are scaling back
h3 STAT Plus: Elevance buys IU Health’s insurance company
h3 STAT Plus: CVS removes top Aetna leader as higher medical costs eat further into profits
h2 Podcasts
h3 Genentech’s cancer pivot, Pfizer’s sickle cell withdrawal, and a new schizophrenia drug
h3 Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
h3 A new threat to Merck’s blockbuster cancer treatment, Moderna’s cutbacks, and obesity drugs for kids
h3 Summit’s upcoming cancer results, Recursion’s mixed data, and a new co-host

Cómo resolver problemas con statnews.com

Los errores en el sitio web de statnews.com pueden ser del lado del servidor o de su lado (lado del cliente). Si no hay prácticamente nada que hacer con los errores del lado del servidor (solo queda esperar para que el sitio vuelva a funcionar), luego, con errores en el lado del cliente, es posible resolver el problema con la disponibilidad de statnews.com por su cuenta.